| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Unilab Corporation |
| 18448 Oxnard Street, Tarzana, CA 91356 * (818) 996-7300 |
| Business Description | The company is the largest independent clinical laboratory testing company in California and one of the largest in the nation. |
| Offering Information Company has | |||
| Trading As | ULAB (NASNTL) | Industry | Service (SIC 8071) |
| Type of Stock Offered | Common Shares | Filing Date | 5/3/2001 |
| Domestic Shares Offered | 6,700,000 | Offer Date | 6/5/2001 |
| Foreign Shares Offered | 0 | Filing Range | $14.00 - $16.00 |
| Company Shares | 6,700,000 | Offer Price | $16.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $1.120 |
| Gross Proceeds | $107,200,000 | Selling | $0.670 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 32,204,300 | Employees | 3550 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Salomon Smith Barney | Lead Manager | (212) 723-7300 |
| CS First Boston | Co-manager | (212) 325-2000 |
| U.S. Bancorp Piper Jaffray | Co-manager | (612) 342-6220 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 6/30/1998 | 6/30/1999 | 6/30/2000 | 12/31/1999 | 12/31/2000 | ||
| Revenues | - | - | 5.350 | 3.159 | 16.123 | 7.537 | 12.266 |
| Income from Oper. | - | - | -1.675 | -1.643 | -2.822 | -0.870 | -1.059 |
| Net Income | - | - | -1.691 | -1.573 | -2.727 | -0.851 | -1.735 |
| E.P.S | - | - | -0.890 | -0.570 | -0.730 | -0.250 | -0.410 |
| Revenue Growth (%) | - | - | -40.95 | 410.383 | 62.74 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -2.28 | -1.03 | -1.78 | ||||
| Cash Flow - Inv. | -3.02 | -0.80 | -3.58 | ||||
| Cash Flow - Fin. | 6.13 | 1.65 | 5.00 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/2000 | Financial Ratios | ||||
| Total Assets | 11.48 | Current Assets | 6.06 | Current Ratio | 1.71 |
| Total Liab. | 5.82 | Current Liab. | 3.55 | Debt Ratio | 50.65% |
| Total Equity | 5.67 | Working Cap. | 2.52 | Debt to Equity Ratio | 1.03 |
| Cash | 0.81 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay outstanding indebtedness and to compensate Kelso & Company as consideration for the termination of annual fees for the provision of financial advisory services to our company. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Skadden, Arps, Slate, Meagher & Flom |
| Bank's Law Firm | Debevoise & Plimpton |
| Auditor | Deloitte & Touche |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |